Characterization of t(2;5) reciprocal transcripts and genomic breakpoints in CD30+ cutaneous lymphoproliferations

Blood

Volumn 91, Issue 12, 1998, Pages 4668-4676

  Beylot Barry, M ^a   Groppi, A ^b   Vergier, B ^b   Pulford, K ^b   Merlio, J P ^b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; NUCLEOPLASMIN; PROTEIN KINASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHROMOSOME 2; CHROMOSOME 5; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATORY DISEASE; LYMPHOMATOID PAPULOSIS; MALE; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN LYMPHOMA; T CELL LYMPHOMA;

EID: 0031811607     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.12.4668     Document Type: Article

References (55)

1. Beljaards RC, Kaudewitz P, Berti E, Gianotti R, Neumann C, Rosso R, Paulli M, Meijer C, Willemze R: Primary cutaneous CD-30+ large cell lymphoma: Definition of a new type of cutaneous lymphoma with a favorable prognosis. Cancer 71:2097, 1993
2. Paulli M, Berti E, Rosso R, Boveri E, Kindl S. Klersy C, Lazzarino M, Borroni G, Menestrina F, Santucci M, Gambini C, Vassallo G, Magrini U, Sterry W, Burg G, Geerts ML, Meijer CJLM, Willemze R. Feller AC, Müller-Hermelink HK, Kadin ME: CD30/Ki-1-positive lymphoproliferative disorders of the skin-clinicopathologic correlation and statistical analysis of 86 cases: A multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group. J Clin Oncol 13:1343, 1995
3. Vergier B, Beylot-Barry M, Pulford K, Michel P, Bosq J, DeMuret A, Beylot C, Delaunay MM, Avril M, Dalac S, Bodemer C, Joly P, Groppi A, DeMascarel A, Bagot M, Mason DY, Wechsler J, Merlio JP: Statistical evaluation of diagnostic and prognostic features of cutaneous CD30+ lymphoproliferative disorders: A clinicopathological study of 65 cases. Am J Surg Pathol (in press)
4. Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S, Diaz-Perez JL, Geerts ML, Goos M, Knobler R, Ralfkiaer E, Santucci M, Smith N, Wechsler J, van Vloten WA, Meijer CJ: EORTC classification for primary cutaneous lymphomas: A proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 90:354, 1997
5. Kadin M: Lymphomatoid papulosis and associated lymphomas. Arch Dermatol 129:351, 1993
6. Willemze R, Beljaards R: Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferations disorders. J Am Acad Dermatol 28:973, 1993
7. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B. Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink H-K, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA: A revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group. Blood 84:1361, 1994
8. Davis TH, Morton CC, Miller-Cassman R: Hodgkin's disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone. N Engl J Med 326:1115, 1992
9. Wood G, Bahler D, Hoppe R, Warnke R, Sklar J, Levy R: Transformation of mycosis fungoides: T-cell receptor b gene analysis demonstrates a common clonal origin for plaque-type mycosis fungoides and CD30+ large-cell lymphoma. J Invest Dermatol 101:296, 1993
10. Morris S, Kirstein M, Valentine M, Dittmer K, Shapiro D, Saltman D, Look A: Fusion of a kinase gene, ALK, to a nucleolar protein gene. NPM, in non-Hodgkin's lymphoma. Science 263:1281, 1994
11. Morris SW, Naeve C, Mathew P, James PL, Kirstein MN, Cui X, Witte DP: ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK). Oncogene 14:2175, 1997
12. Fujimoto J, Shiota M, Iwahara T, Seki N, Satoh H, Mori S, Yamamoto T: Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5). Proc Nat Acad Sci USA 93:4181, 1996
13. Bischop D, Pulford K, Mason DY, Morris SW: Role of the nucleophosmin portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis. Mol Cell Biol 17:2312, 1997
14. Kuefer M, Look T, Pulford K, Behm F, Pattengale P, Mason D, Morris S: Retrovirus-mediated gene transfer of NPM-ALK causes lymphoid malignancy in mice. Blood 90:2901, 1997
15. Downing J, Shurtleff S, Zielenska M, Curcio-Brint A, Behm F, Head D, Sandlung J, Weisenburger D, Kossakowska A, Thorner P, Lorenzana A, Ladanyi M, Morris S: Molecular detection of the (2;5) translocation of non-Hodgkin's lymphoma by reverse transcriptase-polymerase chain reaction. Blood 85:3416, 1995
16. Goran Elmberger P, Lozano M, Weisenburger D, Sanger W, Chan W: Transcripts of the npm-alk fusion gene in anaplastic large cell lymphoma. Hodgkin's disease, and reactive lymphoid lesions. Blood 86:3517, 1995
17. Wellmann A, Otsuki T, Vogelbruch M, Clark HM, Jaffe ES, Raffeid M: Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease. Blood 86:2321, 1995
18. Lopategui J, Sun L, Chan J, Gaffey M, Frierson H, Glackin C, Weiss L: Low frequency association of the t(2;5)(p23;q35) chromosomal translocation with CD30+ lymphomas from American and Asian patients. Am J Pathol 146:323, 1995
19. Sarris AH, Luthra R, Papadimitracopoulou V, Waasdorp M, Dimopoulos MA, McBride JA, Cabanillas F, Duvic M, Deisseroth A, Morris SW, Pugh WC: Long-range amplification of genomic DNA detects the t(2;5)(p23;q35) in anaplastic large-cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis. Ann Oncol 8:59, 1997
20. DeCoteau J, Butmarc JR, Kinney M, Kadin M: The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: Comparison with anaplastic large-cell lymphoma of nodal origin. Blood 87:3437, 1996
21. Beylot-Barry M, Lamant L, Vergier B, DeMuret A, Fraitag S, Delord B, Dubus P, Vaillant L, Me Grogan G, Beylot C, DeMascarel A, Delsol G, Merlio JP: Detection of t(2;5)(p23;q35) translocation by reverse transcriptase polymerase chain reaction and in situ hybridization in CD-30-positive primary cutaneous lymphoma and lymphomatoid papulosis. Am J Pathol 149:483, 1996
22. Wood GS, Hardman DL, Boni R, Dummer R, Kim YH, Smoller BR, Takeshita M, Kikuchi M, Burg G: Lack of the t(2;5) or other mutations resulting in expression of anaplastic lymphoma kinase catalytic domain in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's disease. Blood 88:1765, 1996
23. Sarris AH, Luthra R, Papadimitracopoulou V, Waasdorp M, Dimopoulos MA, McBride JA, Cabanillas F, Duvic M, Deisseroth AB, Morris SW, Pugh WC: Amplification of genomic DNA demonstrates the presence of the t(2;5)(p23;q35) in anaplastic large cell lymphoma but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis. Blood 88:1771, 1996
24. Li G, Salhany KE, Rook AH, Lessin SR: The pathogenesis of large cell transformation in cutaneous T-cell lymphoma is not associated with t(2;5)(p23;q35) chromosomal translocation. J Cutan Pathol 24:403, 1997
25. Orscheschek K, Merz H, Hell J, Feller A: Presence of the t(2;5) in Hodgkin's disease. Blood 86:4383, 1995
26. Herbst H, Anagnostopoulos J, Heinze B, Dürkop H, Hummel M, Stein H: ALK gene products in anaplastic large cell lymphomas and Hodgkin's disease. Blood 86:1694, 1995
27. Weiss L, Lopategui J, Sun L, Kamel O, Koo C, Glackin C: Absence of the t(2;5) in Hodgkin's disease. Blood 85:2845, 1995
28. Downing J, Ladanyi M, Raffeld M, Weiss L, Morris S: Large-cell anaplastic lymphoma-specific translocation in Hodgkin's disease (letter). Lancet 345:918, 1995
29. Merz H, Orscheschek K, Schlegelberger B, Feller A: Large-cell anaplastic lymphoma-specific translocation in Hodgkin's disease. Lancet 345:920, 1995
30. Chan W, Elmberger G, Lozano M, Sanger W, Weisenburger D: Large-cell anaplastic lymphoma-specific translocation in Hodgkin's disease (letter). Lancet 345:921, 1995
31. Lamant L, Meggetto F, AI Saati T, Brugières L, Bressac de Paillerets B, Dastugue N, Bernheim A, Rubié H, Terrier-Lacombe MJ, Robert A, Brousset P, Rigal F, Schlaifer D, Shiota M, Mori S, Delsol G: High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, RT-PCR and p80 immunostaining. Blood 87:284, 1996
32. Poppema S: Large-cell anaplastic lymphoma-specific translocation in Hodgkin's disease. Lancet 345:919, 1995
33. Trümper L, Daus H, Merz H, von Bonin F, Loftin U, Cochlovius C, Moller P, Feller AC, Pfreundschuh M: NPM-ALK fusion mRNA expression in Hodgkin and Reed-Sternberg cells is rare but does occur: Results from single-cell cDNA analysis. Ann Oncol 8:83, 1997
34. Pulford K, Lamant L, Morris SW, Butler LH, Wood KM, Stroud D, Delsol G, Mason DY: Detection of anaplastic-lymphoma-kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK 1. Blood 89:1394, 1997
35. Shiota M, Fujimoto J, Takenaga M, Satoh H, Ichinohasama R, Abe M, Nakano M, Yamamoto T, Mon S: Diagnosis of t(2;5) (p23;q35)-associatedKi-1 lymphoma with immunohistochemistry. Blood 84:3648, 1994
36. Ladanyi M, Cavalchire G: Detection of NPM-ALK genomic rearrangement of Ki-1 lymphoma and isolation of the involved NPM and ALK introns. Diagn Mol Pathol 5:154, 1996
37. Sambrook J, Fritsch E, Maniatis T: Molecular Cloning: A Laboratory Manual (ed 2). Cold Spring Harbor, NY, Cold Spring Harbor Laboratory. 1989
38. Pearson WR, Lipman DJ: Improved tools for biological sequence comparison. Proc Natl Acad Sci USA 85:2444, 1988
39. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ: Basic local alignment search tool. J Mol Biol 215:403, 1990
40. Waggott W, Lo YM, Bastard C, Gatter KC, Leroux D, Mason DY, Boultwood J, Wainscoat JS: Detection of NPM-ALK DNA rearrangement in CD30 positive anaplastic large cell lymphoma. Br J Haematol 89:905, 1995
41. + cutaneous lymphoproliferative disorders. Blood 88:3240, 1996
42. Yee H, Ponzoni M, Merson A, Goldstein M, Scarpa A, Chilosi M, Menestrina F, Pittaluga S, De Wolf-Peeters C, Shiota M, Mori S, Frizzera G, Inghirami G: Molecular characterization of the t(2;5)(p23; q35) translocation in anaplastic large cell lymphoma (Ki-1) and Hodgkin's disease. Blood 87:1081, 1996
43. Biernaux C, Loos M, Sels A, Huez G, Stryckmans P: Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. Blood 86:3118, 1995
44. Limpens J, de Jong D, van Krieken J, Price C, Young B, van Ommen G, Kluin P: bc12/jH rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene 6:2271, 1991
45. Limpens J, Stad R, Vos C, de Vlaam C, de Jong D, van Ommen G, Schuuring E, Kluin P: Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. Blood 85:2528, 1995
46. Lee M, Chang K, Cabanillas F, Freireich E, Trujillo J, Stass S: Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification. Science 237:175, 1987
47. Trümper L, Daus H, Bonin F, Loftin U, Küpper M, Pfreundschuh M: NPM/ALK fusion mRNA expression occurs in peripheral blood B-lymphocytes of healthy donors as evidenced by reverse transcriptase polymerase chain reaction (RT-PCR). Blood 88:225a, 1996 (abstr, suppl 1)
48. Orscheschek K, Merz H, Hell J, Binder T, Bartels H, Feller AC: Large-cell anaplastic lymphoma-specific translocation (t[2;5] [p23; q35]) in Hodgkin's disease: Indication of a common pathogenesis? Lancet 345:87, 1995
49. Pezzella F, Tse AG, Cordell JL, Pulford KA, Gatter KC, Mason DY: Expression of the bcl-2. Am J Pathol 137:225, 1990
50. Pittaluga S, Wlodarska I, Pulford K, Campo E, Morris S, Van den Berghe H, De Wolf-Peeters C: The monoclonal antibody ALK1 indentifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements. Am J Pathol 151:343, 1997
51. Delsol G, Lamant L, Mariame B, Pulford K, Dastugue N, Brousset P, Rigal-Huguet F, AI Saati T, Cerretti DP, Morris SW, Mason DY: A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2;5 translocation. Blood 89:1483, 1997
52. Jauch A, Robson L, Smith A: Investigations with fluorescence in situ hybridization (FISH) demonstrate loss of the telomeres on the reciprocal chromosome in three unbalanced translocations involving chromosome 15 in the Prader-Willi and Angelman syndromes. Hum Genet 96:345, 1995
53. Raynaud S, Cavé H, Baens M, Bastard C, Cacheux V, Grosgeorge J, Guidal-Giroux C, Guo C, Vilmer E, Maryenen P, Grandchamp B: The 12;21 translocation involving TEL and deletion of the other TEL allele: Two frequently associated alterations found in childhood acute lymphoblastic leukaemia. Blood 87:2891, 1996
54. Melo J, Gordon D, Cross N, Goldman J: The ABL-BCR fusion gene is expressed in chronic myeloid leukemia. Blood 81:158, 1993
55. Ladanyi M, Cavalchire G: Molecular variant of the NPM-ALK rearrangement of the Ki-1 lymphoma involving a cryptic ALK splice site. Genes Chromosom Cancer 15:173, 1996